Skip to main content

MATLOCTM Platform Pipeline

MATLOC has the potential to test for multiple biomarkers for effective disease screening and diagnosis at point-of-care.

 

group 2181
matloclogo1st Generation*
Screening Device
 
 
 
  • For care provider use in and outside the clinic
  • Easy use with lab-on-chip insert
  • Quantitatively measures urine ACR; Albumin-to-creatinine ratio (ACR)
  • Device will be handheld with Bluetooth capabilities
  • Quantitative results will transfer to smartphone cloud-based App

group 3470

group 2182
matloclogo2nd Generation*
Diagnostic Device
 
 
 
 
All the features of MATLOC 1, PLUS:
  • The ability to test for blood based eGFR
  • MATLOC 2 could revolutionize CKD care by providing accessible, inexpensive, quantitative and integrated CKD screening, diagnosis, and risk prediction analysis
  • There are currently no quantitative hand-held, point-of-care diagnostic devices available for the measurement of both ACR and eGFR.
imgfooter